Navigation Links
Melanoma in Medical Technology

Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy

... survival rates in patients with metastatic melanoma whose disease had been minimized by other ... interest in developing new therapies for melanoma patients with recurrent or distant metastatic ... for the study. "Patients with metastatic melanoma are at high risk for additional metastases and ...

USC Keck School of Medicine's Dr. Alan Epstein Receives Prestigious National Cancer Institute RAID Award for Breakthrough IL-2 Molecule Therapeutic

... immunotherapy is used to treat metastatic melanoma and metastatic renal cell carcinoma, diseases ... States each year, respectively. An increase in melanoma incidence has elevated the disease to the sixth ... 60,000 Americans developed invasive cutaneous melanoma in 2007, with an estimated additional 48,000 or ...

CuraGen Updates CR011-vcMMAE Data at ASCO

... Demonstrated in Advanced Breast Cancer and melanoma - - Conference call to be hosted Wednesday, ... in patients with advanced breast cancer and melanoma at the 2009 Annual Meeting of the American ... trial of CR011-vcMMAE in patients with advanced melanoma were presented at a poster discussion session. ...

Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer

... Offer Hope of First Highly Effective Drug in melanoma Along With Companion Diagnostic BASEL, ... promising treatment for patients with advanced melanoma whose cancer harbours the BRAF mutation (known as ... liver, lung and bone[i]. Historically, metastatic melanoma patients live less than two months before their ...

Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting

... only melanoma Immunological effects and clinical outcomes in patients with high-risk melanoma given adjuvant therapy with ... investigator: Lynn Spitler, Northern California melanoma Center, Saint Mary's Medical Center, San ...

CuraGen to Present CR011-vcMMAE Data at ASCO

... - Update from Advanced Breast Cancer and melanoma Studies - Conference Call to be Hosted on ... in patients with advanced breast cancer and melanoma at the 2009 Annual Meeting of the American ... the safety and efficacy in the treatment of melanoma and for the treatment of metastatic breast ...

Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types

... melanoma; other Novartis data on advanced melanoma also presented EAST HANOVER, N.J., May 28 ... age norms on most domains(6). Highlights in melanoma New data highlight the potential of two ... melanoma, the most serious form of skin cancer. melanoma accounts for 41,000 deaths worldwide each ...

AlphaVax Announces Promising Results in Melanoma Studies

... melanoma-specific tumor antigens to reduce melanoma tumor burden in a state-of-the-art murine melanoma model. Jedd D. Wolchok, M.D., Ph.D., Lab ... oncologist who specializes in the treatment of melanoma and in whose laboratory the work was conducted. ...

Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis

... estimate that nearly one-third of cases of melanoma , the most serious form of skin cancer, are ... their 30s or 40s, coupled with the fact that melanoma is the most common form of cancer for young ... old, more women could be faced with developing melanoma before or during pregnancy. At the recent ...

Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint

... patients with unresectable stage III or stage IV melanoma was stopped early following a planned interim ... these data might have on other ongoing Nexavar melanoma trials. Data from this study are expected to be ... patients with unresectable stage III or stage IV melanoma at more than 200 clinical sites in the United ...

Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results

... Results at The Sixth International Symposium on melanoma and Other Cutaneous Malignancies in New York City ... 2 clinical trial for the treatment of metastatic melanoma are as good as or better than Phase 1 data. ... efforts at The Sixth International Symposium on melanoma and Other Cutaneous Malignancies on March 13, ...

Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey

... for the treatment of invasive and metastatic melanoma by the FDA's Office of Orphan ... . About Metastatic melanoma The American Cancer Society has estimated ... of, and approximately 8,400 deaths from, melanoma will occur in 2008 in the United States. ...

CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma

... and Professor and Chairman of the Department of melanoma Medical Oncology, at The University of Texas ... to be clinically active against unresectable melanoma in some patients. We look forward to ... providing updated data from the ongoing melanoma and breast cancer studies in the first half of ...

Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients

... to high risk and advanced-stage melanoma -- an often fatal form of cancer for which there ... an immune response -- that are commonly found in melanoma tumors. These antigens stimulate T-cells within ... the next cycle of treatment. About Melanoma melanoma is the most serious form of skin cancer, ...

CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma

... and Professor and Chairman of the Department of melanoma Medical Oncology at The University of Texas, M.D. ... with CR011-vcMMAE. Completing enrollment in this melanoma study ahead of schedule highlights the external ... Treatment of Patients with Advanced melanoma Type: Oral presentation Presenter: Dr. ...

Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology

... investigational anti-CTLA-4 antibody, in melanoma are scheduled to be the subject of presentations ... -- "Efficacy and safety of patients with advanced melanoma treated with ipilimumab with or without the ... in ipilimumab-treated patients with advanced melanoma - results from a Phase 2, ...

CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE

... - Results from Phase II melanoma Trial Expected in the Fourth Quarter - ... enrollment of patients into the Phase II melanoma trial," commented Dr. Tim Shannon, President and ... we look forward to completing enrollment in the melanoma study and subsequently presenting updated results ...

Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival

... with pegylated interferon alfa-2b in stage III melanoma patients had a significant and sustained impact ... term pegylated interferon therapy in stage III melanoma had a significant and sustained impact on ... alfa-2b is not approved for treatment of melanoma in either the US or EU. About The Study The ...

CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer

... updated CR011-vcMMAE results for the treatment of melanoma by the end of 2008 and the presentation of ... A Phase II study of CR011-vcMMAE in patients with melanoma is currently enrolling patients, and ... the use of CR011-vcMMAE for breast cancer, melanoma and gliomas, and the timeframe of initiating ...

Patient's Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation

... blood cell, from a 52-year-old man whose Stage 4 melanoma had spread to a groin lymph node and to a lung. T cells specific to targeting the melanoma were then expanded vastly in the laboratory using ... be used for the 25 percent of all late-stage melanoma patients who have the same immune-system type and ...

Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial

... ongoing Allovectin-7(R) Phase 3 metastatic melanoma trial. Through a series of cash payments and ... patients with Stage III or IV metastatic melanoma in accordance with a Special Protocol Assessment ... for the treatment of invasive and metastatic melanoma by the FDA's Office of Orphan Products ...

CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma

... CR011- vcMMAE in patients with advanced melanoma utilizes a Simon 2-Stage design with a primary ... Melanoma The number of people diagnosed with melanoma is rapidly increasing. It is expected that approximately 60,000 new cases of melanoma will be diagnosed and an estimated 8,000 people ...

Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients

... -- Results from an adjuvant trial in high-risk melanoma patients demonstrated that a majority of ... may be a potential adjuvant therapy for high-risk melanoma patients," said E. George Elias M.D., Ph.D., Director of Maryland melanoma Center. "The percentage of patients who achieved ...

Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center

... trial for the treatment of inoperable metastatic melanoma in the liver using the Company's Percutaneous ... Luke's. Dr. Agarwala, a leader in the field of melanoma and clinical oncology, commented, ... with metastatic ocular and cutaneous melanoma who have unresectable tumors in the liver. The ...

CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma

... "The overexpression of the GPNMB protein by melanoma makes it an intriguing and novel therapeutic ... patients with unresectable Stage III or Stage IV melanoma who have failed no more than one prior line of ... the safety and efficacy in the treatment of melanoma and will enter Phase II during the third quarter ...

BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting

... CA. Fifty patients with inoperable Stage IIIc/IV melanoma were enrolled. Patients were given OncoVEX GM-CSF ... in Dallas, TX said: "Patients with advanced melanoma have few current treatment options that produce a ... more than 8,000 people died in the U.S. of melanoma in 2007. Prevalence of Stage III and Stage ...

New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma

... immunotherapy as a treatment for metastatic melanoma and non-small cell lung cancer (NSCLC). These ... regarding the use of the genetic profiling of melanoma in predicting clinical outcomes of treatment with MAGE-A3 ASCI. Biopsies performed on the melanoma tumors prior to immunization were used to ...

Genasense(R) Chemotherapy Program Yields High Response Rate in Patients with Stage 4 Melanoma

... hours. An amendment to the above pilot trial in melanoma is planned that will incorporate this more ... our ongoing Phase 3 AGENDA trial in patients with melanoma and low-normal LDH. We also plan that melanoma will be a target for our development program with ...

Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma

... analysis showed that stage IV metastatic melanoma patients treated with elesclomol and paclitaxel ... any indication in any market. "The incidence of melanoma has continued to rise in recent years and there ... potentially, other cancer types." Metastatic melanoma occurs ...

BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting

... IL on Sunday, June 1 at 9:30am EDT during the melanoma conference session. A summary of the abstract ... more than 8,000 people died in the U.S. of melanoma in 2007. Prevalence of stage III and stage ... Stage IV disease is six months. Treatment of melanoma depends on the stage of the disease with ...

Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology

... "Antitumor response and new lesions in advanced melanoma patients on ipilimumab treatment" (Abstract ... -- "Long-term survival of patients with advanced melanoma who received ipilimumab administered at ... and efficacy in patients with advanced melanoma treated with ipilimumab with or without ...

Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report

... approved therapies and had refractory metastatic melanoma before receiving Allovectin-7(R). One patient had ... for the treatment of invasive and metastatic melanoma by the FDA's Office of Orphan Products ... of, and approximately 8,400 deaths from, melanoma will occur in 2008 in the United States. ...

CuraGen Advances CR011-vcMMAE into Phase II

... for advanced melanoma - - Preliminary Phase I/II results to be ... Professor and Chairman of the Department of melanoma Medical Oncology at M.D. Anderson Cancer Center, ... Melanoma The number of people diagnosed with melanoma is rapidly increasing. It is expected that ...

New Study Shows Proprietary Canola Extract, Dermytol(TM), Produces Pronounced Decrease in Malignant Melanoma Tumor Volume

... produces a pronounced reduction of malignant melanoma cell growth. Dermytol(TM), a proprietary ... year. NCI expects more than 8,000 deaths from melanoma and less than 1,000 deaths from non-melanoma ... all of the mice were injected with malignant melanoma tumor cells. Dermytol(TM) or placebo treatments ...

Medarex Announces Ipilimumab Program Continues to Move Forward

... (study 024) for front- line treatment of advanced melanoma is different in design from the Pfizer trial, and ... patients with previously untreated metastatic melanoma (front-line). Ipilimumab is administered at 10 ... . About Advanced Melanoma melanoma is a form of skin cancer characterized by the ...

AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma

... it shows activity against human tumors including melanoma and is synergistic with alkylating agents ... candidate may offer to patients with malignant melanoma the most serious form of skin cancer." About Metastatic Melanoma Metastatic melanoma is the most deadly form of skin cancer, ...

Researchers Train the Immune System to Deliver Virus That Destroys Cancer in Lab Models

... -- Two days after treatment, the presence of melanoma tumor cells in lymph nodes was significantly ... both the lymph nodes and spleen were free of melanoma tumor cells. -- Mice treated with a single ... developed a potent T-cell response against melanoma tumor cells. -- Although the procedure was ...

IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients

... updated results from a Phase 2 UVIDEM(R) (IDD-3) melanoma vaccine clinical trial (DC-MEL-202). The updated ... mature dendritic cells loaded with lysates from melanoma tumor cell lines. UVIDEM is produced in IDM ... announced. Thirty-eight patients with malignant melanoma were included in the U.S. Phase 2 study and 53 ...

CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma

... with unresectable Stage III or IV malignant melanoma have been treated with CR011-vcMMAE in the Phase ... co-Principal Investigator, Co-Director of the melanoma Program at the Yale Cancer Center in New Haven, ... patients with unresectable Stage III or Stage IV melanoma who have failed no more than one prior line of ...

Recipient of Melanoma Drug in Development Celebrates Two Cancer-Free Years

... to treat forms of cancer. "Mr. Hora had multiple melanoma reoccurrences in the previously treated area of ... being investigated by Provectus for treatment of melanoma and other focal forms of cancer. "When it is ... 2 trial will treat up to eighty Stage III/IV melanoma patients at seven or more sites in Australia and ...
Other Contents
(Date:8/28/2014)... FASEB MARC (Maximizing Access to Research Careers) Program ... Society of Human Genetics from October 18 22, ... meant to promote the entry of students, post doctorates ... the basic science community and to encourage the participation ... Genetics. This year MARC conferred 16 awards totaling ...
(Date:8/28/2014)... MD FASEB MARC (Maximizing Access to Research ... for the Genetics Society of America,s 27th Annual ... October 3, 2014 in Pacific Grove, California. ... of students, post doctorates and scientists from underrepresented ... community and to encourage the participation of young ...
(Date:8/28/2014)... Aug. 28, 2014  Privacy Advocate and Senior Staff ... Lynch , joins the lineup of biometric and mobile ... Biometrics UnPlugged Executive Summit in Tampa, Florida ... Previously announced speakers include Steven Rahman, Director, Technology and Strategy ... at Experian. The theme of this year,s event is ...
Breaking Biology News(10 mins):Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2
(Date:8/31/2014)... 31, 2014 To make it easy ... they can trust, NutriGold is shipping complimentary samples of ... has been set up to make taking advantage of ... According to Priya Khan, Director of Research and Development ... one of our products, they are entrusting us with ...
(Date:8/31/2014)... Rockville, MD (PRWEB) August 31, 2014 ... electronic health records (EHR) software firm that focuses ... overall practice success found a congruent commitment with ... In Sports . , “We create an environment ... and effortlessly, allowing more time with patients,” says ...
(Date:8/31/2014)... Richmond, CA (PRWEB) August 31, 2014 ... program of the California State Library, celebrates 30 ... and their families. Since its inception, California’s Library ... a million Californians learn to read and write. ... this volunteer-based program, the state is launching a ...
(Date:8/31/2014)... Wine only protects against cardiovascular disease (CVD) in people ... Veritas (IVV) study presented at ESC Congress today by ... Taborsky said: "This is the first randomised trial comparing ... of atherosclerosis (1) in people at mild to moderate ... was only protective in people who exercised. Red and ...
(Date:8/30/2014)... A retrievable and repositionable transcatheter aortic valve is ... according to research presented at ESC Congress 2014 ... direct flow medical (DFM) transcatheter aortic valve has ... the potential to improve transcatheter aortic valve implantation ... , Dr Pyxaras said: "TAVI is well established ...
Breaking Medicine News(10 mins):Health News:Whole-food Supplement Samples Now Offered by NutriGold 2Health News:Whole-food Supplement Samples Now Offered by NutriGold 3Health News:Powerhouse EHR, Future Health, Announces Gold Sponsorship of POWERPlay in Sports National Tour 2Health News:Powerhouse EHR, Future Health, Announces Gold Sponsorship of POWERPlay in Sports National Tour 3Health News:Powerhouse EHR, Future Health, Announces Gold Sponsorship of POWERPlay in Sports National Tour 4Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:Wine only protects against CVD in people who exercise 2Health News:Retrievable transcatheter aortic valve effective and safe in real world setting 2
Other TagsOther Tags